Gevo, Inc. annual report, Q4 FY2010

Business Context and Reporting Period

Company: Gevo, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2010
Business Overview: Gevo is a development-stage renewable chemicals and advanced biofuels company focused on commercializing isobutanol produced from renewable feedstocks using its proprietary Gevo Integrated Fermentation Technology (GIFT). The company's strategy involves retrofitting existing ethanol facilities to produce isobutanol, which serves as a building block for plastics, fibers, rubber, and hydrocarbon fuels. As of the reporting date, Gevo had not yet generated revenue from isobutanol sales; revenue was derived primarily from government grants and the recent acquisition of an ethanol production facility.

Key Financial Metrics

Metric 2010 2009 2008
Total Revenues $16.4 million $0.7 million $0.2 million
Cost of Goods Sold ($13.4 million) $0 $0
Gross Margin $3.0 million $0.7 million $0.2 million
Net Loss ($40.1 million) ($19.9 million) ($14.5 million)
Net Loss Attributable to Common Stockholders ($42.9 million) ($19.9 million) ($14.5 million)
Cash and Cash Equivalents (Year End) $15.3 million $21.2 million $9.6 million
Total Assets $51.6 million $26.4 million $13.1 million
Total Liabilities $31.7 million $11.3 million $9.9 million
Secured Long-Term Debt (Net) $20.4 million $7.7 million $8.2 million
Accumulated Deficit ($85.3 million) ($42.4 million) ($23.1 million)

Note: Revenue in 2010 includes $14.8 million from ethanol sales following the September 2010 acquisition of Agri-Energy. Prior to this acquisition, revenue consisted solely of government grants.

Material Changes vs. Prior Period

  • Revenue Surge: Total revenues increased 2,384% to $16.4 million, driven almost entirely by the acquisition of Agri-Energy, LLC in September 2010, which contributed $14.8 million in ethanol sales. Grant revenue also increased 126% to $1.5 million.
  • Increased Net Loss: Net loss widened to $40.1 million (up 102% from 2009). This was primarily due to a 172% increase in Selling, General, and Administrative (SG&A) expenses to $23.6 million and a 41% increase in Research and Development (R&D) expenses to $14.8 million.
  • Debt Expansion: Secured long-term debt increased significantly to $20.4 million (up from $7.7 million) due to new borrowings from TriplePoint Capital ($17.5 million total) used to fund the Agri-Energy acquisition and repay prior debt.
  • Asset Growth: Total assets nearly doubled to $51.6 million, reflecting the addition of Agri-Energy's property, plant, and equipment ($20.6 million) and inventory.

Guidance, Outlook, and Risks

Management Commentary and Outlook

  • Commercialization Timeline: Gevo expects to begin commercial production of isobutanol at the retrofitted Agri-Energy facility in Luverne, Minnesota, in the first half of 2012. The projected retrofit cost is approximately $22 million.
  • Strategic Goal: The company aims to produce and sell over 350 million gallons of isobutanol by 2015 by retrofitting additional ethanol facilities.
  • Customer Pipeline: Gevo has entered into non-binding letters of intent with major potential customers including LANXESS, Total Petrochemicals, Toray Industries, United Airlines, and Sasol. A binding exclusive supply agreement with LANXESS was signed in January 2011 (post-period).
  • Liquidity: As of December 31, 2010, the company held $15.3 million in cash. Management believes this, combined with proceeds from an Initial Public Offering (IPO) completed in February 2011 ($110.4 million net), will fund operations for at least 12 months.

Risks and Contingencies

  • Development Stage Risks: Gevo has incurred net losses since inception and has no history of profitable operations. There is no guarantee it will achieve profitability.
  • Retrofit Execution: The Agri-Energy retrofit is the company's first commercial-scale project. Risks include cost overruns, delays, and technical failures in scaling the GIFT technology.
  • Intellectual Property Litigation: In January 2011, Butamax (a joint venture of BP and DuPont) filed a lawsuit alleging Gevo infringes on a patent for isobutanol production. Gevo intends to contest this vigorously.
  • Regulatory Approvals: Commercialization depends on obtaining EPA fuel certification and FDA approval for protein fermentation meal (a co-product), which could be delayed or denied.
  • Market Acceptance: Success depends on refiners and chemical producers accepting isobutanol as a drop-in replacement for petroleum-based products.

Key Facts for Investor Verification

  • Revenue Source: Verify that 90% of 2010 revenue came from ethanol sales (Agri-Energy), not the core isobutanol business, which had zero revenue.
  • Debt Covenants: Review the terms of the TriplePoint and Lighthouse loan agreements, which restrict dividends and further borrowing until specific milestones (e.g., isobutanol production) are met.
  • IP Litigation Status: Monitor the outcome of the patent infringement lawsuit filed by Butamax in January 2011, as an adverse judgment could restrict operations.
  • Retrofit Costs: Track the actual capital expenditure required to retrofit the Agri-Energy facility against the projected $22 million estimate.
  • Customer Agreements: Confirm the conversion of non-binding letters of intent (LOIs) with major partners (LANXESS, United Airlines, etc.) into definitive, binding supply contracts.
  • Regulatory Milestones: Verify the timeline for EPA fuel certification and FDA approval for animal feed co-products.